NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis.
Saved in:
| Title: | NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis. |
|---|---|
| Authors: | Chen Y; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Dai S; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zhuang L; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Cai W; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Chen H; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zhao J; Department of Oncology, Shaoxing Central Hospital, Shaoxing, China.; Department of Oncology, The Central Affiliated Hospital, Shaoxing University, Shaoxing, China., Zhang F; Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; Graduate School of Anhui University of Traditional Chinese Medicine, Hefei, China., Chen L; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. lianyu-chen@alu.fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. lianyu-chen@alu.fudan.edu.cn., Cheng CS; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. natcheng@connect.hku.hk.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. natcheng@connect.hku.hk. |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2026 Feb; Vol. 33 (2), pp. 171-185. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41388151 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Dai+S%22">Dai S</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+L%22">Zhuang L</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cai+W%22">Cai W</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Oncology, Shaoxing Central Hospital, Shaoxing, China.; Department of Oncology, The Central Affiliated Hospital, Shaoxing University, Shaoxing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+F%22">Zhang F</searchLink>; Oncology Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; Graduate School of Anhui University of Traditional Chinese Medicine, Hefei, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. lianyu-chen@alu.fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. lianyu-chen@alu.fudan.edu.cn.<br /><searchLink fieldCode="AU" term="%22Cheng+CS%22">Cheng CS</searchLink>; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. natcheng@connect.hku.hk.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. natcheng@connect.hku.hk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 2026 Feb; Vol. 33 (2), pp. 171-185. <i>Date of Electronic Publication: </i>2025 Dec 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5500 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41388151 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41417-025-00995-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 171 Titles: – TitleFull: NRAV promotes HCC stemness via the m6A-regulated let-7c-5p/LIN28B axis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Dai S – PersonEntity: Name: NameFull: Zhuang L – PersonEntity: Name: NameFull: Cai W – PersonEntity: Name: NameFull: Chen H – PersonEntity: Name: NameFull: Zhao J – PersonEntity: Name: NameFull: Zhang F – PersonEntity: Name: NameFull: Chen L – PersonEntity: Name: NameFull: Cheng CS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5500 Numbering: – Type: volume Value: 33 – Type: issue Value: 2 Titles: – TitleFull: Cancer gene therapy Type: main |
| ResultId | 1 |